TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysisArielle J. Medford, Aditya Bardia, Sofia Menshikova et al.|Therapeutic Advances in Medical Oncology|2023Cited by 11
Abstract P1-18-22: AKT inhibition in combination with endocrine therapy and a CDK4/6 inhibitor (CDK4/6i) in patients with hormone receptor positive (HR+)/HER2 negative metastatic breast cancer (MBC) and prior CDK4/6i exposure: A translational investigationSeth A. Wander, Aditya Bardia, Douglas S. Micalizzi et al.|Cancer Research|2022Cited by 1